Pear releases schizophrenia therapeutic after FDA loosens digital health regulations during pandemic

Pear releases schizophrenia therapeutic after FDA loosens digital health regulations during pandemic

To open up access to mental health services during the Coivd-19 pandemic, the FDA is allowing digital health companies to release products that have not yet been approved. Under this temporary guidance, Pear Therapeutics launched limited distribution of a digital therapeutic for people with schizophrenia.

Source: https://ift.tt/2SjD2pq